High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina

PURPOSE: The purpose of this study was to evaluate the efficacy of HDR brachytherapy for primary or recurrent vaginal cancer. METHODS: Between the years 2000 to 2006, 18 patients with primary or recurrent vaginal cancer were treated with brachytherapy (HDRB). Six patients had primary vaginal cancer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Beriwal, Sushil, Heron, Dwight E, Mogus, Robert, Edwards, Robert P, Kelley, Joseph L, Sukumvanich, Paniti
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2008
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2270281/
https://ncbi.nlm.nih.gov/pubmed/18271958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-3-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars